Fulcrum Equity Management’s Idexx Laboratories IDXX Stock Holding History

Fulcrum Equity Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,422	Closed	-$1.59M	–	148
2021 Q4	$1.59M	Sell	2,422 -92	-4%	-$57.8K	0.6%	48
2021 Q3	$1.56M	Sell	2,514 -903	-26%	-$607K	0.61%	47
2021 Q2	$2.16M	Sell	3,417 -794	-19%	-$438K	0.81%	41
2021 Q1	$2.06M	Buy	4,211 +17	+0.4%	+$8.52K	0.81%	42
2020 Q4	$2.1M	Buy	+4,194	New	+$1.88M	0.84%	44
2019 Q4	–	Sell	-23	Closed	-$6K	–	144
2019 Q3	$6K	Buy	+23	New	+$6.4K	﹤0.01%	146

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Fulcrum Equity Management's IDXX Position: Q1 2022 in Review

Fulcrum Equity Management sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 2,422 shares — an estimated $1.59M sold.

Fulcrum Equity Management first reported a position in IDXX in Q3 2019 and held it in 6 quarters. The position peaked at $2.16M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Fulcrum Equity Management reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Fulcrum Equity Management sold 2,422 Idexx Laboratories shares in Q1 2022, an estimated $1.59M.
Fulcrum Equity Management first reported a position in Idexx Laboratories in Q3 2019 and held it in 6 quarters.
Fulcrum Equity Management's Idexx Laboratories position peaked at $2.16M in Q2 2021.
1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Fulcrum Equity Management's 13F filing for Q1 2022, filed 15 Apr 2022.